【2026 TMU X BE PoC Program｜Applications Open!】 Taiwan’s leading medical innovation accelerator is now accepting applications! Designed to help health-tech teams move from technology → clinical validation → market entry.
Timeline Applications: Now–Jan 19, 2026 Review: Jan–Feb 2026 Program Start: Mar 2026
Program Benefits Clinical validation with Taipei Medical University and Show Chwan Healthcare System. 100+ global mentors for 1:1 guidance on Asia and global markets. Corporate partners including AstraZeneca, Sanofi, Google, Qualcomm, Rohto, Teijin, and more. Focus areas: digital health, AI in medicine, surgical innovation, medical devices. Courses covering market expansion, business model, regulations, and fundraising.
Program Fee: USD 6,500 Includes full access to clinical support, commercialization guidance, and global exposure.
1 TMU performance report
Clinical consultations (incl. study design discussion)
